On 18 December 2019, our new EUROIMMUN subsidiary in Japan was officially founded after one year of hard work, intensive planning and structuring. Head of this new subsidiary is Cagla Egretaud, who has been working at EUROIMMUN for 20 years. The idea to jointly establish a new subsidiary in Japan, one of the world’s largest […]
Five years ago, the ICAP initiative on harmonisation and standardisation in the nomenclature of HEp-2 IFA patterns was implemented at the International Workshop on Autoantibodies and Autoimmunity (IWAA) in São Paulo, Brazil. Luis E. C. Andrade, professor at the Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, has been involved from the
Recently, a new law on measles vaccination has been passed in Germany. As of March 2020, all children in Germany from the age of one year must present proof of their vaccination against measles, as recommended by the Standing Committee on Vaccination (StiKO), before their admission into crèche, kindergarten, school or other childcare, such as
Recently, a very interesting review article on the diagnostics of bullous dermatoses has been published in Frontiers of Immunology, a peer-reviewed journal. The publication is authored by EUROIMMUN scientists, who were invited to write an expert review article on this important topic. Over the past few years, EUROIMMUN has become a true leader in this
This months, EUROIMMUN has celebrated a small milestone: a total of 100 EUROLabWorkstation (ELW) have been completed, 65 ELW ELISA and 35 ELW IFA. Since their introduction to the market in 2017 and 2019, respectively, the systems have been successfully installed with customers worldwide, including leading laboratory chains in the USA, Germany and Brazil. The
